ICI-related GIT events, which account for 30% of all ICI-related adverse events, occur in 0.3–7% of the treatment population group, thus making it a highly significant issue [ 6 ].
1
—
—
ICI-related GIT events, which account for 30% of all ICI-related adverse events, occur in 0.3–7% of the treatment population group, thus making it a highly significant issue [ 6 ].